The company also picked up clearance under the MDSAP program, giving broad access to international markets. Authorization covers the majority of the company’s products, including:
- HiPoint 70/Tenzing 7 Reperfusion System
- HiPoint 88/Tenzing 8 Reperfusion System
- FreeClimb 70/Tenzing 7 Reperfusion System
- FreeClimb 88/Tenzing 8 Reperfusion System
- Base Camp Sheath System
Route 92 develops a suite of reperfusion and access systems leveraging the patented Tenzing delivery catheter. The products aim to improve the efficiency of endovascular thrombectomy procedures. The company designed its technology to enable the quick restoration of blood flow to the brain following acute ischemic stroke.